Peripheral Vascular Devices Market to Reach USD 19.36 Billion by 2034 at 5.4% CAGR

Peripheral Vascular Devices Market Overview

The Peripheral Vascular Devices Market was valued at USD 12.06 billion in 2025 and is expected to reach USD 19.36 billion by 2034, expanding at a CAGR of 5.4% during the 2026–2034 forecast period. The sector covers devices used to diagnose and treat vascular conditions affecting vessels outside the heart and brain, including peripheral arterial disease, aneurysms, arterial injuries and related disorders. MMR highlights minimally invasive intervention and continuing device innovation as central growth forces.

Request for sample copy of this report: https://www.maximizemarketresearch.com/request-sample/1389/

The sector is increasingly influenced by drug-eluting technologies, advanced catheter systems, intravascular imaging, embolic protection, chronic total occlusion solutions and bioresorbable materials. MMR notes that drug-eluting stents and drug-coated balloons are important trends because they deliver therapeutic agents to vessel walls and address restenosis after intervention.

Key Growth Drivers Fueling the Peripheral Vascular Devices Market

Rising vascular disease burden: MMR identifies the increasing prevalence of peripheral vascular disorders and an aging population as major demand catalysts. This supports wider use of minimally invasive vascular interventions.

Advanced catheter technologies: Angiography, IVUS/OCT and guiding catheters are improving visualization, lesion assessment and device placement. Better imaging and maneuverability can support more precise treatment.

Drug-eluting innovation: Drug-eluting stents and drug-coated balloons deliver therapeutic agents directly to vessel walls. Their role in reducing restenosis is strengthening adoption in peripheral angioplasty.

Flow-alteration and access devices: Embolic protection systems, chronic total occlusion devices, guidewires, vascular closure systems and introducer sheaths are expanding treatment options for complex procedures.

Next-generation materials: MMR highlights improved biocompatibility, flexibility, durability and bioresorbable materials as important opportunities for devices intended to reduce long-term complications.

Market Segmentation  By Type, Application & End-Use

The Peripheral Vascular Devices Market is segmented by MMR across device type, indication, artery and end user:

• Device Type: Peripheral Vascular Stents — dominant device segment, including self-expanding, balloon-expanding and covered stents; Drug-Eluting Stents; Drug Eluting Balloons; Peripheral Vascular Bioresorbable Scaffolds.
• Indication: Target Artery Instability, Access Artery Injury, Peripheral Arterial Disease, Arteriovenous Fistulas, Peripheral Aneurysms and Others.
• Artery: Carotid Artery, Fem-Pop Artery, Iliac Artery and Infrapop Artery.
• End User: Hospitals, Ambulatory Surgical Centers/Outpatients and Cardiac Catheterization Labs.

MMR states that peripheral vascular stents held the highest device-type market share in 2025 and are projected to generate the maximum revenue. Its public description does not disclose an exact percentage share for that segment or percentage shares for the other segmentation categories, so no unsupported percentages are added.

Regional Analysis — Where Is the Peripheral Vascular Devices Market Growing Fastest?

United States

MMR describes the United States as the largest producing and consuming country in North America. Its strong manufacturing ecosystem includes companies such as Abbott Laboratories and Boston Scientific.

United Kingdom

The United Kingdom is included in MMR’s European country analysis. Lombard Medical Technologies is listed among European key players, but the public summary gives no UK-specific share or CAGR.

Germany

Germany is covered within MMR’s European forecast. B. Braun Melsungen, Biotronik and Jotec are listed among leading European companies headquartered there.

Japan

Japan forms part of the Asia Pacific analysis. MMR lists Terumo Corporation and Asahi Intecc among the region’s leading companies.

South Korea

South Korea is included in MMR’s Asia Pacific forecast across device type, indication, artery and end user. No country-specific market share or growth rate is published in the accessible summary.

China

China is included among MMR’s Asia Pacific countries. The public report provides country-level forecast coverage but no standalone China market value or percentage share.

India

India is included in the Asia Pacific forecast. MMR also reports that Abbott introduced the XIENCE Skypoint stent in India in March 2026, while no India-specific market share is disclosed.

North America is the dominant region and is expected to hold the highest share. MMR’s public summary does not identify a fastest-growing region or one top investment hotspot, so those rankings are not inferred.

Competitive Landscape  Leading Companies in the Peripheral Vascular Devices Market

MMR specifically names Medtronic, Abbott Laboratories and Boston Scientific as top key players; its wider leading-player list also includes Cook Medical and Cardinal Health.

1. Medtronic plc  MMR cites its March 2026 agreement to acquire Scientia Vascular, strengthening vascular access and interventional capabilities.
2. Abbott Laboratories  Active in stents and vascular technologies, with recent India commercialization and CE Mark progress for the Esprit BTK scaffold noted by MMR.
3. Boston Scientific Corporation MMR highlights its imaging and chronic total occlusion technologies used in vascular interventions.
4. Cook Medical Incorporated  Listed among leading North American companies and associated with introducer-sheath innovation.
5. Cardinal Health, Inc.  Included in MMR’s North American competitive landscape.

Request for sample copy of this report: https://www.maximizemarketresearch.com/request-sample/1389/

Recent Developments & Strategic Moves

• Medtronic announced an agreement in March 2026 to acquire Scientia Vascular for USD 550 million, according to MMR.
• Avantec Vascular received U.S. FDA 510(k) clearance in February 2026 for a specialized thrombectomy system for peripheral venous vessels.
• Johnson & Johnson launched the Shockwave Javelin Peripheral IVL Catheter across Europe in September 2025 for heavily calcified lesions.
• Abbott secured CE Mark approval for its Esprit BTK bioresorbable scaffold system in August 2025 for below-the-knee disease.
• In digital procedure guidance, Philips expanded commercial availability of its AI-enabled LumiGuide 3D navigation technology, while Siemens Healthineers offers AI-supported angiography tools for vascular intervention workflows.

AI & Digital Transformation Impact on Peripheral Vascular Devices Market

How is AI changing the Peripheral Vascular Devices Market? AI is increasingly being incorporated into imaging, navigation and workflow support around vascular procedures. AI-supported angiography can help optimize image quality and procedural visualization, while digital 3D navigation can provide clinicians with more contextual guidance during minimally invasive interventions.

These tools complement the IVUS/OCT, angiography and catheter innovations highlighted by MMR. The strategic direction is toward integrated procedural ecosystems that connect vascular devices with imaging, navigation and digital workflow technologies.

Future Outlook — Investment Opportunities & Emerging Trends

The future of the Peripheral Vascular Devices Market will be shaped by next-generation stents, drug-coated technologies, bioresorbable scaffolds, thrombectomy, embolic protection, intravascular imaging and digital guidance. MMR’s projection from USD 12.06 billion in 2025 to USD 19.36 billion by 2034 at 5.4% CAGR supports continued investment in minimally invasive platforms, materials innovation, catheter engineering and scalable vascular-care infrastructure.

Related Reports

Global Topical Antibiotics Market https://www.maximizemarketresearch.com/market-report/global-topical-antibiotics-market/101031/

Global Telemedicine Technologies and Service Market https://www.maximizemarketresearch.com/market-report/global-telemedicine-technologies-and-service-market/15761/

global Big Data Healthcare Market https://www.maximizemarketresearch.com/market-report/global-big-data-healthcare-market/65588/

Expert Commentary

"According to Komal Patil, Research Manager at Maximize Market Research, 'The Peripheral Vascular Devices Market is projected to rise from USD 12.06 billion in 2025 to USD 19.36 billion by 2034 at a CAGR of 5.4%, reflecting sustained demand for minimally invasive vascular interventions. Investment opportunities are increasingly centered on advanced stents, drug-eluting technologies, bioresorbable platforms and digitally supported workflows that can improve procedural precision and treatment accessibility.'"

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting company that provides reliable, data-focused, and practical business insights. The firm serves a wide range of industries, including healthcare, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. Through market forecasts, competitive analysis, strategic consulting, and industry impact assessments, MMR helps organizations understand changing market conditions, identify growth opportunities, and make informed business decisions for long-term success.

Contact Us

2nd Floor, Navale IT Park Phase 3

Pune Banglore Highway, Narhe

Pune, Maharashtra 411041, India

+91 9607365656

sales@maximizemarketresearch.com 

https://www.maximizemarketresearch.com